The cyclln A, B1, D1 and E expression in advanced non-small cell lung cancer - Stages IIIB-IV (preliminary report);Ekspresja cyklin A, B1, D1 i E w zaawansowanym niedrobnokomórkowym raku płuca - Stadia IIIB-IV (doniesienie wstȩpne)

Polski Merkuriusz Lekarski

Volumn 30, Issue 178, 2011, Pages 253-258

  Kosacka, Monika ^a,b   Piesiak, Paweł ^a   Porebska, Irena ^a   Korzeniewska, Anna ^a   Jankowska, Renata ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cyclin A; Cyclin B1; Cyclin D1; Cyclin E; Non small cell lung cancer (NSCLC); Prognostic factor

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN E; CYCLINE; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN E; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79957522049     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ayeda A. K., Adesina A.: Prognostic significance of cyclin D1 expression in resected stage I, II non-small cell lung cancer in Arabs. Interact. Cardio Vasc. Thorac. Surg. 2006, 5, 47-51. (Pubitemid 43200167)
2. Biemat W., Kordek R., Potemski P., Kusińska R.: Histoklinika rate pŁica. Grzelewska-Rzymowska I.: Rak płuca. Wydawnictwo Sesja 2003, Łodź. 45-60.
3. Bortner D. M., Rosenberg M. P.: Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol. 1997, 17, 453-459. (Pubitemid 26425635)
4. Caputi M., Groeger A. M., Esposito V. i wsp.: Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am. J. Respir. Cell. Mol. Biol. 1999, 20, 746-750. (Pubitemid 129495786)
5. Didkowska J.: Epidemiologia i etiopatogeneza nowotworów płuca i opłicnej. Nowotwory płuca i opłucnej - praktyczny przewodnik dla lekarzy (red. Jassem J., Krzakowski M.) Via Medica, Gdańsk, 2006, 1-18.
6. Dobashi Y., Jiang S. X., Shoji M. i wsp.: Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas. J. Pathol. 2003, 199, 2, 208-220. (Pubitemid 36176027)
7. Dworakowska D.: Rola bialka p53, pRB, p21WAF1/CIP1, PCNA, mdm2 oraz cykliny D1 w regulacji cyklu komórkowego oraz apoptozy. Onkol. Pol. 2005, 8, 4, 223-228.
8. Esposito V., Baldi A., de Luca A. i wsp.: Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J. Clin. Pathol. 2005, 58, 734-739. (Pubitemid 40956829)
9. Innocente S. A., Abrahamson J. LA., Cogswell J. P., Lee J. M.: p53 regulates a G2 checkpoint through cyclin B1. PNAS. 1999, 96, 5, 2147-2152. (Pubitemid 29117882)
10. Lonardo F., Rusch V., Langenfeld J. i wsp.: Overexpression of cyclins D1 and e is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res. 1999, 59, 2470-2476. (Pubitemid 29242299)
11. Mac Lachlan T. K., Sang N., Giordano A.: Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene. Expr. 1995, 5, 2, 127-156.
12. Mishina T., Dosaka-Akita H., Hommura F. i wsp.: Cyclin e expression, a potential prognostic marker for non-small cell lung cancers. Clin. Cancer Res. 2000, 6, 11-16. (Pubitemid 30064970)
13. Mishina T., Dosaka-Akita H., Kinoshita I. i wsp. Cyclin D1 expression in non-small-cell lung cancer: its association with altered p53 expression, cell proliferation and clinical outcome. Br. J. Cancer 1999, 80, 8, 1289-1295.
14. Mountain C. F.: The international system for staging lung cancer. Semin. Surg. Oncol. 2000, 18, 2, 106-115. (Pubitemid 30090451)
15. Nguyen V. N., Mirejovsky P., Mirejovský T. i wsp.: Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer prognostic significance and comparison with p53 and bcl-2. Acta Histochem.. 2000, 102, 3, 323-38. (Pubitemid 30660146)
16. Othsubo M., Theodoras A. M., Schumacher J. i wsp.: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 1995, 15, 5, 2612-2624.
17. Rivera A., Mavila A., Bayless K. J. i wsp.: Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells. Cell. Mol. Life Sci. 2006, 63, 1425-1439. (Pubitemid 43939022)
18. Sherr Ch. J.: The pezcoller lecture: Cancer cell cycles revisited. Cancer Res. 2000, 60, 14, 3689-3695.
19. Singhal S., Vachani A., Antin-Ozerkis D. i wsp.: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer a review. Clin. Cancer Res. 2005, 11, 3974-3986. (Pubitemid 40791561)
20. Skuladottir H., Olsen J. H.: Epidemiology of lung cancer In: Spiro S. G (red) Lung cancer, ERS Journals 2001, Ltd, Sheffield, 1-12.
21. Soria J. Ch., Jang S. J., Khuri F. R. i wsp.: Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 2000, 60, 4000-4004. (Pubitemid 30636572)
22. Strauss G. M., Kwiatkowski D. J., Harpole D. H. i wsp.: Molecular and pathologic markers in stage i non-small-cell carcinoma of the lung. J. Clin. Oncol. 1995, 13, 1265-1279.
23. Survival of Cancer Patients in Europe: the Eurocare-3 study. Ann Oncol 2003, 14, suppl. http://eurocare.it/
24. Volm M., Koomagi R., Mattern J., Stammler G.: Cyclin A is associated with unfavourable outcome in patients with non-small-cell lung carcinomas. Br. J. Cancer 1997, 75, 12, 1774-1778. (Pubitemid 27230702)
25. Welch H. G., Schwartz L. M., Woloshin S.: Are increasing 5-year survival rates evidence of success against cancer? Jama 2000, 283, 2975-2978. (Pubitemid 30414510)
26. Yang R., Mueller C., Huynh V. i wsp.: Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol. Cell. Biol. 1999, 19, 2400-2407. (Pubitemid 29098297)
27. Yoo J., Jung J. H., Lee M. A. i wsp.: Immunohistochemical analysis of nonsmall cell lung cancer correlation with clinical parameters and prognosis. J. Korean Med. Sci. 2007, 22, 2, 318-325.
28. Yoshida T., Tanaka S., Mogi A. i wsp.: The clinical significance of cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann. Oncol. 2004, 15, 252-256. (Pubitemid 38262624)
29. Zdrojewicz Z., Belowska-Bień K.: Cyklina E-nowy marker w onkologii? Adv. Clin. Exp. Med. 2004, 13, 6, 1023-1028.
30. Zhu C. Q., Shih W., Ling C. H., Tsao M. S.: Immunohistochemical markers of prognosis in non-small cell lung cancer a review and proposal for a multiphase approach to marker evaluation. J. Clin. Pathol. 2006, 59, 8, 790-800. (Pubitemid 44211740)